國立虎尾科技大學 |

Immunotherapy of Melanoma

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Immunotherapy of Melanoma/ by Anand Rotte, Madhuri Bhandaru.
Author:	Rotte, Anand.
other author:	Bhandaru, Madhuri.
Description:	XI, 434 p. 59 illus., 52 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Cancer research. -
Online resource:	https://doi.org/10.1007/978-3-319-48066-4
ISBN:	9783319480664

Immunotherapy of Melanoma
Rotte, Anand.

Immunotherapy of Melanoma[electronic resource] /by Anand Rotte, Madhuri Bhandaru. - 1st ed. 2016. - XI, 434 p. 59 illus., 52 illus. in color.online resource.

Preface -- Melanoma -- Tumor immunology -- Immune based drugs approved for treatment of melanoma -- Promising immunotherapeutic approaches in clinical trials -- Challenges of immunotherapy -- Index.

This book focusses on the different types of immunotherapeutics that are currently being used and developed for the treatment of melanoma. In recent years, immunotherapy has revolutionized the treatment of metastatic melanoma and other types of cancer. Discussing treatment options for melanoma and the success of immunotherapy along with the challenges of immunotherapy, this book covers epidemiology, susceptibility genes, and treatment recommendations from Society for Immunotherapy of Cancer, as well as immune based therapies such as aldesleukin, Intron-A, Sylatron, Yervoy, Opdivo, Keytruda, Imlygic, DC vaccines and adoptive cell therapy. The detailed information included on the key immune cells involved in anti-tumor immune response and immune-inhibitory mechanisms in tumor microenvironment will aid the understanding of tumor immunology. Both academic as well as industry-based researchers, developing novel anti-cancer therapies, will also benefit from the details of promising molecular targets and immunotherapeutic strategies under investigation. With 132 illustrations including synopsis tables for important information, over 1200 references (majority of which are openly accessible) and details of more than 150 ongoing clinical trials, this book is a valuable source of information for health care providers as well as cancer biologists interested in learning about melanoma and the significant advances made by immunotherapy. .

ISBN: 9783319480664

Standard No.: 10.1007/978-3-319-48066-4doiSubjects--Topical Terms:

1253664
Cancer research.

LC Class. No.: RC261-271

Dewey Class. No.: 614.5999

Immunotherapy of Melanoma
LDR:03001nam a22003975i 4500 001 976567
003 DE-He213
005 20200629194207.0
007 cr nn 008mamaa
008 201211s2016 gw | s |||| 0|eng d
020 $a 9783319480664 $9 978-3-319-48066-4
024 7 $a 10.1007/978-3-319-48066-4 $2 doi
035 $a 978-3-319-48066-4
050 4 $a RC261-271
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 614.5999 $2 23
100 1 $a Rotte, Anand. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1116181
245 1 0 $a Immunotherapy of Melanoma $h [electronic resource] / $c by Anand Rotte, Madhuri Bhandaru.
250 $a 1st ed. 2016.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a XI, 434 p. 59 illus., 52 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Preface -- Melanoma -- Tumor immunology -- Immune based drugs approved for treatment of melanoma -- Promising immunotherapeutic approaches in clinical trials -- Challenges of immunotherapy -- Index.
520 $a This book focusses on the different types of immunotherapeutics that are currently being used and developed for the treatment of melanoma. In recent years, immunotherapy has revolutionized the treatment of metastatic melanoma and other types of cancer. Discussing treatment options for melanoma and the success of immunotherapy along with the challenges of immunotherapy, this book covers epidemiology, susceptibility genes, and treatment recommendations from Society for Immunotherapy of Cancer, as well as immune based therapies such as aldesleukin, Intron-A, Sylatron, Yervoy, Opdivo, Keytruda, Imlygic, DC vaccines and adoptive cell therapy. The detailed information included on the key immune cells involved in anti-tumor immune response and immune-inhibitory mechanisms in tumor microenvironment will aid the understanding of tumor immunology. Both academic as well as industry-based researchers, developing novel anti-cancer therapies, will also benefit from the details of promising molecular targets and immunotherapeutic strategies under investigation. With 132 illustrations including synopsis tables for important information, over 1200 references (majority of which are openly accessible) and details of more than 150 ongoing clinical trials, this book is a valuable source of information for health care providers as well as cancer biologists interested in learning about melanoma and the significant advances made by immunotherapy. .
650 0 $a Cancer research. $3 1253664
650 0 $a Oncology . $3 1253469
650 1 4 $a Cancer Research. $3 668358
650 2 4 $a Oncology. $3 593951
700 1 $a Bhandaru, Madhuri. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1116182
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319480657
776 0 8 $i Printed edition: $z 9783319480671
776 0 8 $i Printed edition: $z 9783319838908
856 4 0 $u https://doi.org/10.1007/978-3-319-48066-4
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)